Your browser doesn't support javascript.
loading
Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer.
Zhao, Qi; Hughes, Rachel; Neupane, Binod; Mickle, Kristin; Su, Yun; Chabot, Isabelle; Betts, Marissa; Kadambi, Ananth.
Afiliação
  • Zhao Q; Global Value & Access, Eisai Inc, Woodcliff Lake, NJ, USA.
  • Hughes R; Evidence Synthesis, Modeling & Communication, Evidera, San Francisco, CA, USA.
  • Neupane B; Evidence Synthesis, Modeling & Communication, Evidera, Montreal, QC, Canada.
  • Mickle K; Evidence Synthesis, Modeling & Communication, Evidera, Waltham, MA, USA.
  • Su Y; Global Value & Access, Eisai Inc., Woodcliff Lake, NJ, USA.
  • Chabot I; Faculté de pharmacie, University of Montreal, Montreal, QC, Canada.
  • Betts M; Evidence Synthesis, Modeling & Communication, Evidera, Waltham, MA, USA.
  • Kadambi A; Evidence Synthesis, Modeling & Communication, Evidera, San Francisco, CA, USA. ananth.kadambi@evidera.com.
BMC Cancer ; 21(1): 758, 2021 Jun 30.
Article em En | MEDLINE | ID: mdl-34193107
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Furanos / Cetonas Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Furanos / Cetonas Idioma: En Ano de publicação: 2021 Tipo de documento: Article